Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
- Submitting institution
-
Queen's University of Belfast
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 87457978
- Type
- D - Journal article
- DOI
-
10.1016/S1470-2045(15)00193-X
- Title of journal
- Lancet Oncology
- Article number
- -
- First page
- 1295
- Volume
- 16
- Issue
- 13
- ISSN
- 1470-2045
- Open access status
- Out of scope for open access requirements
- Month of publication
- September
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
16
- Research group(s)
-
-
- Citation count
- 220
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to carrying out the study and helped draft output
- Non-English
- No
- English abstract
- -
